A Study to Assess the PK and Pharmacodynamics of IPX203 in Subjects With Advanced Parkinson's Disease
Clinical trial NCT03007888 · COMPLETED
Trial details
- NCT number
- NCT03007888
- Sponsor
- Impax Laboratories, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-14
- Primary completion
- 2017-08-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.